查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592931

失眠治療藥物市場：按類型、分銷管道分類 - 全球預測 2025-2030 年

Insomnia Drugs Market by Type (Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants), Distribution Channels (Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年失眠治療藥物市場規模為29.2億美元，預計2024年將達30.7億美元，複合年成長率為5.67%，2030年將達43億美元。

失眠藥物市場包括旨在改善失眠患者睡眠品質和持續時間的藥物。失眠的特徵是難以入睡和維持睡眠，需要有效的藥物治療，如苯二氮平類、非苯二氮平類安眠藥、褪黑激素受體促效劑、Orexin受體拮抗劑等。由於壓力、生活方式的改變和人口老化，失眠症越來越普遍，凸顯了對市場的需求。失眠治療藥物旨在透過恢復規律的睡眠模式來改善患者的 QOL（生活品質），並被各種最終用戶使用，包括醫院、診所和家庭護理機構。關鍵的成長要素包括心理健康意識的增強以及對先進睡眠障礙治療的需求。此外，醫療保健支出的增加和藥物配方的技術進步也帶來了潛在的機會。透過遠端醫療平台以及與醫療保健提供者的合作擴大治療的可近性可以擴大您的市場範圍。然而，挑戰仍然存在，包括與長期使用相關的副作用、嚴格的監管核准以及無副作用的替代療法的出現，例如認知行為療法。為了解決這些局限性，需要進行研究，重點是開發副作用較少的藥物和解決個人化治療方法的個人化醫療方法。快速藥物輸送系統和針對調節睡眠的核心途徑的藥物的創新可能會推動市場成長。投資於非成癮、天然、永續的睡眠輔助產品的研發可以使公司在這個競爭激烈的市場中脫穎而出。此外，利用穿戴式科技和睡眠監測應用程式等數位健康工具提供了增強患者參與和結果追蹤的機會，從而提供有價值的真實世界資料見解。儘管目前面臨挑戰，但該市場預計將出現顯著成長，特別是在開發結合藥物治療和針對患者需求的生活方式介入的協同治療方面。

主要市場統計
基準年[2023] 29.2億美元
預測年份 [2024] 30.7億美元
預測年份 [2030] 43億美元
複合年成長率（%） 5.67%

市場動態：揭示快速發展的失眠藥物市場的關鍵市場洞察

供需的動態交互作用正在改變失眠藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球失眠盛行率不斷上升
    • 提高對失眠各種治療方案的認知
  • 市場限制因素
    • 與失眠藥物相關的副作用
  • 市場機會
    • 持續研究並開發新的失眠療法
    • 增加失眠中心和睡眠診斷中心
  • 市場挑戰
    • 對失眠嚴重性和患者不遵從治療的誤解

波特五力：駕馭失眠藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對失眠治療市場的影響

外部宏觀環境因素在塑造失眠治療藥物市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解失眠治療藥物市場競爭狀況

對失眠治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 失眠治療藥物市場供應商定位矩陣績效評估

FPNV 定位矩陣是評估失眠治療藥物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪失眠治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對失眠治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球失眠盛行率增加
      • 提高對失眠不同治療方法的認知
    • 抑制因素
      • 與失眠藥物相關的副作用
    • 機會
      • 新研發失眠治療藥物
      • 增加失眠和睡眠診斷中心
    • 任務
      • 對失眠嚴重程度和患者不堅持治療的誤解
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章失眠治療藥物市場：依類型

  • 抗帕金森氏症藥物
  • 抗驚厥藥
  • 抗憂鬱症
  • 抗發作性睡病藥
  • 苯二氮平類
  • 非苯二氮平類藥物
  • Orexin拮抗劑
  • 拉梅爾席恩

第7章按分銷管道分類的失眠治療藥物市場

  • 網路藥房
  • 零售藥房

第8章 北美與南美失眠治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太失眠治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲失眠治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Alembic Pharmaceuticals Limited
  • Astellas Pharma Inc.
  • Aurobindo Pharma Limited
  • Biogen SA
  • Cadila Healthcare Ltd.
  • Dr.Reddy's Laboratories Limited
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Flynn Pharma Limited
  • Glenmark Pharmaceuticals Ltd.
  • Idorsia Pharmaceuticals Ltd.
  • LA Herbal（India）
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Minerva Neurosciences, Inc.
  • Neuracle Lifesciences Private Limited
  • Neurim Pharmaceuticals LTD.
  • Orexo AB
  • Pfizer Inc.
  • Purdue Pharma LP
  • Sanofi Group
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Vanda Pharmaceuticals Inc.
  • Wockhardt Limited
Product Code: MRR-F6513A06BE94

The Insomnia Drugs Market was valued at USD 2.92 billion in 2023, expected to reach USD 3.07 billion in 2024, and is projected to grow at a CAGR of 5.67%, to USD 4.30 billion by 2030.

The insomnia drugs market encompasses pharmaceutical products designed to improve sleep quality and duration in individuals experiencing insomnia. Insomnia, characterized by difficulty in falling or staying asleep, necessitates effective medications like benzodiazepines, non-benzodiazepine hypnotics, melatonin receptor agonists, and orexin receptor antagonists. The growing prevalence of insomnia, driven by stress, lifestyle changes, and an aging population, underscores the market's necessity. It finds application across various end-users, including hospitals, clinics, and homecare settings, aiming to improve patient quality of life by restoring regular sleep patterns. Key growth factors include the increasing awareness of mental health and the need for advanced sleep disorder treatments. Additionally, rising healthcare expenditure and technological advancements in drug formulation present potential opportunities. Expanding the accessibility of treatments through telemedicine platforms and collaborations with healthcare providers can enhance market reach. However, challenges persist in the form of side effects associated with long-term usage, stringent regulatory approvals, and the emergence of side-effect-free alternative therapies like cognitive behavioral therapy. Addressing these limitations involves research focused on developing drugs with reduced adverse effects and personalized medicine approaches for individualized treatment regimens. Innovations in rapid drug delivery systems and drugs targeting core sleep-regulating pathways could advance market growth. Investment in R&D for non-addictive, natural, and sustainable sleep aid products could differentiate companies within this competitive market. Moreover, utilizing digital health tools, such as wearable technology and sleep monitoring apps, offers opportunities to enhance patient engagement and outcome tracking, providing valuable real-world data insights. Despite current challenges, the market holds significant promise for growth, particularly in the development of synergistic therapies, integrating pharmacological treatments with lifestyle interventions tailored to patient needs.

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.07 billion
Forecast Year [2030] USD 4.30 billion
CAGR (%) 5.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insomnia Drugs Market

The Insomnia Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of insomnia across the world
    • Rising awareness about various treatment options available for insomnia
  • Market Restraints
    • Side effects associated with insomnia drugs
  • Market Opportunities
    • Continuous research and development to develop novel insomnia drugs
    • Increase in number of insomnia centers and sleep diagnostic centers
  • Market Challenges
    • Misconceptions about the seriousness of insomnia and patients' non-adherence to the treatment

Porter's Five Forces: A Strategic Tool for Navigating the Insomnia Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insomnia Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insomnia Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insomnia Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insomnia Drugs Market

A detailed market share analysis in the Insomnia Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insomnia Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insomnia Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insomnia Drugs Market

A strategic analysis of the Insomnia Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insomnia Drugs Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Limited, Astellas Pharma Inc., Aurobindo Pharma Limited, Biogen SA, Cadila Healthcare Ltd., Dr.Reddy's Laboratories Limited, Eisai Co., Ltd., Eli Lilly and Company, Flynn Pharma Limited, Glenmark Pharmaceuticals Ltd., Idorsia Pharmaceuticals Ltd., LA Herbal (India), Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Minerva Neurosciences, Inc., Neuracle Lifesciences Private Limited, Neurim Pharmaceuticals LTD., Orexo AB, Pfizer Inc., Purdue Pharma L.P., Sanofi Group, Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Vanda Pharmaceuticals Inc., and Wockhardt Limited.

Market Segmentation & Coverage

This research report categorizes the Insomnia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants, Antinarcoleptics, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Ramelteon.
  • Based on Distribution Channels, market is studied across Online Pharmacies and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of insomnia across the world
      • 5.1.1.2. Rising awareness about various treatment options available for insomnia
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with insomnia drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous research and development to develop novel insomnia drugs
      • 5.1.3.2. Increase in number of insomnia centers and sleep diagnostic centers
    • 5.1.4. Challenges
      • 5.1.4.1. Misconceptions about the seriousness of insomnia and patients' non-adherence to the treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Insomnia Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Anti-Parkinsonian Drugs
  • 6.3. Anticonvulsants
  • 6.4. Antidepressants
  • 6.5. Antinarcoleptics
  • 6.6. Benzodiazepines
  • 6.7. Nonbenzodiazepines
  • 6.8. Orexin Antagonist
  • 6.9. Ramelteon

7. Insomnia Drugs Market, by Distribution Channels

  • 7.1. Introduction
  • 7.2. Online Pharmacies
  • 7.3. Retail Pharmacies

8. Americas Insomnia Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Insomnia Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Insomnia Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alembic Pharmaceuticals Limited
  • 2. Astellas Pharma Inc.
  • 3. Aurobindo Pharma Limited
  • 4. Biogen SA
  • 5. Cadila Healthcare Ltd.
  • 6. Dr.Reddy's Laboratories Limited
  • 7. Eisai Co., Ltd.
  • 8. Eli Lilly and Company
  • 9. Flynn Pharma Limited
  • 10. Glenmark Pharmaceuticals Ltd.
  • 11. Idorsia Pharmaceuticals Ltd.
  • 12. LA Herbal (India)
  • 13. Mallinckrodt Pharmaceuticals
  • 14. Merck & Co., Inc.
  • 15. Minerva Neurosciences, Inc.
  • 16. Neuracle Lifesciences Private Limited
  • 17. Neurim Pharmaceuticals LTD.
  • 18. Orexo AB
  • 19. Pfizer Inc.
  • 20. Purdue Pharma L.P.
  • 21. Sanofi Group
  • 22. Sun Pharmaceutical Industries Limited
  • 23. Takeda Pharmaceutical Company Limited
  • 24. Vanda Pharmaceuticals Inc.
  • 25. Wockhardt Limited

LIST OF FIGURES

  • FIGURE 1. INSOMNIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. INSOMNIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INSOMNIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INSOMNIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INSOMNIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INSOMNIA DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTI-PARKINSONIAN DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTINARCOLEPTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NONBENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN ANTAGONIST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RAMELTEON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 105. INSOMNIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. INSOMNIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023